Latest Industry Analysis Research Reports By Pharmaceutical Category

Displaying 1 to 30 (of 37032)

  • Global Antihemorrhagic Agent Market Insights, Forecast to 2025

    Antihemorrhagic Agent is a substance that promotes hemostasis (stops bleeding). In 2017, the global Antihemorrhagic Agent market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Antihemorrhagic Agent market based on ...

  • Global Acute Lymphoblastic Leukemia Market Insights, Forecast to 2025

    Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. In 2017, the global Acute Lymphoblastic Leukemia market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this stu...

  • Global Acute Lymphoblastic Leukemia Therapeutics Market Insights, Forecast to 2025

    Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. In 2017, the global Acute Lymphoblastic Leukemia Therapeutics market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objective...

  • Global Acute Lymphoblastic Leukemia Treatment Market Insights, Forecast to 2025

    Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. In 2017, the global Acute Lymphoblastic Leukemia Treatment market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives o...

  • Global Acute Lymphocytic/Lymphoblastic Leukemia Drugs Market Insights, Forecast to 2025

    Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. In 2017, the global Acute Lymphocytic/Lymphoblastic Leukemia Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The obje...

  • Global Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market Insights, Forecast to 2025

    Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. In 2017, the global Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. T...

  • Global Acute Lymphocytic/Lymphoblastic Leukemia Treatment Market Insights, Forecast to 2025

    Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. In 2017, the global Acute Lymphocytic/Lymphoblastic Leukemia Treatment market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The ...

  • Global Ammonia Inhalants (Smelling Salts) Market Insights, Forecast to 2025

    Smelling salts are used to arouse consciousness because the release of ammonia (NH3) gas that accompanies their use irritates the membranes of the nose and lungs, and thereby triggers an inhalation reflex. This reflex alters the pattern of breathing, resulting in improved respiratory flow rates and possibly alertness. In 2017, the global Ammonia In...

  • Global Athletes Foot Drugs Market Insights, Forecast to 2025

    Athlete's foot, known medically as tinea pedis, is a common skin infection of the feet caused by fungus.Signs and symptoms often include itching, scaling, cracking and redness. In rare cases the skin may blister. Athlete's foot fungus may infect any part of the foot, but most often grows between the toes.The next most common area is the bottom of t...

  • Global Blinatumomab Drugs Market Insights, Forecast to 2025

    Blinatumomab (trade name Blincyto) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia. In 2017, the global Blinatumomab Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objec...

  • Global Blinatumomab Market Insights, Forecast to 2025

    Blinatumomab (trade name Blincyto) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia. In 2017, the global Blinatumomab market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives ...

  • Global Blincyto Market Insights, Forecast to 2025

    Blincyto is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia. In 2017, the global Blincyto market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, seg...

  • Global Buffered Intrathecal Electrolyte/Dextrose Injection Drugs Market Insights, Forecast to 2025

    buffered intrathecal electrolyte/dextrose injection is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma. In 2017, the global Buffered Intrathecal Electrolyte/Dextrose Injection Drugs market size was xx million US$ and is fore...

  • Global Buffered Intrathecal Electrolyte/Dextrose Injection Market Insights, Forecast to 2025

    buffered intrathecal electrolyte/dextrose injection is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma. In 2017, the global Buffered Intrathecal Electrolyte/Dextrose Injection market size was xx million US$ and is forecast t...

  • Global Clofarabine Drugs Market Insights, Forecast to 2025

    Clofarabine is a purine nucleoside antimetabolite marketed in the US and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra. In 2017, the global Clofarabine Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of thi...

  • Global Clofarabine Market Insights, Forecast to 2025

    Clofarabine is a purine nucleoside antimetabolite marketed in the US and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra. In 2017, the global Clofarabine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this stud...

  • Global Clolar Market Insights, Forecast to 2025

    Clofarabine is a purine nucleoside antimetabolite marketed in the US and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra. In 2017, the global Clolar market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are...

  • Global Dasatinib Drugs Market Insights, Forecast to 2025

    Dasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). In 2017, the global Dasatinib Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of...

  • Global Elliotts B Solution Market Insights, Forecast to 2025

    Elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma. In 2017, the global Elliotts B Solution market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The...

  • Global Elspar Market Insights, Forecast to 2025

    Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. In 2017, the global Elspar market size was xx million US$ and is forecast to xx...

  • Global Erwinase Market Insights, Forecast to 2025

    Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. In 2017, the global Erwinase market size was xx million US$ and is forecast to ...

  • Global Erwinia L-Asparaginase Drugs Market Insights, Forecast to 2025

    Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. In 2017, the global Erwinia L-Asparaginase Drugs market size was xx million US$...

  • Global Erwinia L-Asparaginase Market Insights, Forecast to 2025

    Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. In 2017, the global Erwinia L-Asparaginase market size was xx million US$ and i...

  • Global Evoltra Market Insights, Forecast to 2025

    Clofarabine is a purine nucleoside antimetabolite in Europe and Australia/New Zealand the product is marketed under the name Evoltra. In 2017, the global Evoltra market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size ...

  • Global Gleevec Market Insights, Forecast to 2025

    Imatinib is a medication used to treat cancer. In 2017, the global Gleevec market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Gleevec market based on company, product type, application and key regions. This re...

  • Global Iclusig Market Insights, Forecast to 2025

    Iclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL).  In 2017, the global Iclusig market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives o...

  • Global Imatinib Mesylate Drugs Market Insights, Forecast to 2025

    Imatinib is a medication used to treat cancer. In 2017, the global Imatinib Mesylate Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Imatinib Mesylate Drugs market based on company, product type, appli...

  • Global Kidrolase Market Insights, Forecast to 2025

    Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. In 2017, the global Kidrolase market size was xx million US$ and is forecast to...

  • Global Marqibo Market Insights, Forecast to 2025

    Marqibo (vinCRIStine sulfate LIPOSOME injection) is vincristine encapsulated in sphingomyelin/cholesterol liposomes for intravenous administration. In 2017, the global Marqibo market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and proje...

  • Global Mercaptopurine Drugs Market Insights, Forecast to 2025

    Mercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases adenine and hypoxanthine.  In 2017, the global Mercaptopurine Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this ...

Displaying 1 to 30 (of 37032)

Let Us Find For You

Difficulty in finding the research that interests your business need? Let us find it for you! One of our Research Specialists will help you locate the research study that will answer your concerns. Please dial in the below numbers and get started.

Mail us : sales@globalqyresearch.com

Copyright © 2018 Global QYResearch